SAFER: A Brief Intervention Involving Family Members in Suicide Safety Planning

Sponsor
VA Office of Research and Development (U.S. Fed)
Overall Status
Completed
CT.gov ID
NCT03034863
Collaborator
(none)
78
1
2
31.9
2.4

Study Details

Study Description

Brief Summary

The management of suicide risk is a pressing national public health issue especially among Veterans, and there exist no guidelines of how best to involve family members in this effort. This proposal will integrate family and couples communication skills training with suicide safety planning. The goal is for the sharing of Veteran suicide safety plans with family members and the construction of a parallel family member safety plan, in efforts to mobilize and support family involvement.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Safe Actions for Families to Encourage Recovery
  • Behavioral: Individual Safety Planning Intervention
N/A

Detailed Description

Psychological models of suicidality emphasize the role of social factors in the development and intensification of suicidal thoughts and behavior, including feeling like a burden on family and friends, feelings of isolation and not belonging, and perceptions of diminished support from one's family and social network. Despite the critical role of family factors in protecting against suicidality, families lack education on how their behavior can help avert or unwittingly aggravate suicidal thoughts/ behavior. Families worry about their relative but feel uncertain of how to help and need professional guidance. Family worries about suicidality are associated with compromised family physical and mental health and consequently, diminished ability to offer needed support. Because suicide safety plans rely on mobilizing support in times of crisis, families need to be equipped to provide needed support.

Family recommendations from the VA Behavioral Health Autopsy Program (BHAP) Annual Report 6/30/15 based on interviews with 114 family members highlighted the importance of:

  1. educating families about suicide warning signs:

  2. improving communication between the veteran and family member

  3. involving the family in the veterans' treatment to enhance support and trust

  4. providing families with coaching on how to assist their loved one to seek help.

Management of suicidal behavior is covered in comprehensive family psychoeducation programs, but there is an urgent need for a brief family-based intervention specifically focused on suicide prevention that can be used in conjunction with the currently mandated SSP and as a part of routine care.

Despite the enrichment of VA suicide prevention services and implementation of the national suicide hotline, Veteran suicide completions have risen to 22 per day and suicide attempts numbered over 15,000 in 2012. These data underscore the urgency of developing additional interventions targeting suicidal Veterans. One potential avenue to further suicide treatment and rehabilitation efforts is to develop strategies that maximize family support, however almost no family interventions exist for suicidal Veterans. The construction of a Suicide Safety Plan (SSP); a "best practice," is mandated throughout the VA system, and a vital component of the VA's coordinated effort at suicide prevention and recovery. The pilot data on patterns of SSP use in suicidal Veterans highlighted the importance of sharing the plan with family or close friends. However, respondents also noted significant obstacles in their ability to reach out to others when in distress. To the knowledge of Investigators, there are currently no recommended guidelines or mechanisms for involving family in safety planning, despite its inclusion as a step of the plan. "Safe Actions for Families to Encourage Recovery" (SAFER) a novel suicide safety planning family intervention has been designed to fill this critical gap and provide a mechanism to communicate about safety planning. SAFER, a 4-session, family intervention, combines education about suicide and suicide safety planning with communication skills training from evidence-based practices. The aim is to facilitate communication about suicide safety planning and to develop both a Veteran and family member safety plan.

Data from this project will test the intervention's feasibility, acceptability and preliminary efficacy in a Stage II small-scale randomized clinical trial in 39 moderate suicide risk Veterans and their supporting partners. The comparison condition will be safety planning without supporting partner involvement plus weekly check-in phone calls. Primary Veteran outcomes include reducing suicidal ideation/behavior. Secondary Veteran outcomes include reducing suicidal cognitions (hopelessness, perceived burdensomeness, thwarted belongingness) and depression and improving subjective social support. Supporting Partner primary outcomes include reducing caregiver burden and secondary outcomes of improving suicide-related coping and family empowerment.

Study Design

Study Type:
Interventional
Actual Enrollment :
78 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Participants are assigned to one of two groups in parallel for the duration of the study.Participants are assigned to one of two groups in parallel for the duration of the study.
Masking:
Single (Outcomes Assessor)
Masking Description:
The individual who evaluates the outcomes of interest will not know the assigned condition of the participants.
Primary Purpose:
Treatment
Official Title:
SAFER: A Brief Intervention Involving Family Members in Suicide Safety Planning
Actual Study Start Date :
Jul 3, 2017
Actual Primary Completion Date :
Dec 31, 2019
Actual Study Completion Date :
Feb 28, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: SAFER

SAFER (Safe Actions for Families to Encourage Recovery): A novel, 5-session intervention to enhance currently mandated VA suicide safety planning by involving supporting partners to support its implementation. Incorporation of education about suicide risk factors and teaching communication skills of active listening and making a positive request will supply Veterans and supporting partners with the knowledge and tools needed to 1) identify potential warning signs, and 2) discuss Veteran ideation or partner concerns with assurance that such requests will be listened to with validation and support, creating an ally for the suicidal Veteran in his struggle. As discussed above, research has demonstrated compellingly that suicidal desire is motivated by two interpersonal factors; perceived burdensomeness and thwarted belongingness. SAFER aims to increase partner support for the Veteran to directly mitigate Veteran loneliness and sense of being a burden to others.

Behavioral: Safe Actions for Families to Encourage Recovery
A novel, 5-session intervention to enhance currently mandated VA suicide safety planning by involving family members to support its implementation. Incorporation of education about suicide risk factors and teaching communication skills of active listening and making a positive request will supply Veterans and family members with the knowledge and tools needed to 1) identify potential warning signs, and 2) discuss Veteran ideation or family concerns with assurance that such requests will be listened to with validation and support, creating an ally for the suicidal Veteran in his struggle. As discussed above, research has demonstrated compellingly that suicidal desire is motivated by two interpersonal factors; perceived burdensomeness and thwarted belongingness. SAFER aims to increase family support for the Veteran to directly mitigate Veteran loneliness and sense of being a burden to others.
Other Names:
  • SAFER
  • Active Comparator: I-SPI

    The comparison condition will be an assessment-only enhanced treatment-as-usual called the Individual Safety Planning Intervention (I-SPI), incorporating weekly scripted check-in phone calls to review mood symptoms and use of the safety plan, which will then be given as feedback to the Veteran's primary mental health provider.

    Behavioral: Individual Safety Planning Intervention
    The comparison condition will be an assessment-only enhanced treatment-as-usual intervention called the Individual Safety Planning Intervention (I-SPI).
    Other Names:
  • I-SPI
  • Outcome Measures

    Primary Outcome Measures

    1. Veteran Suicidal Ideation [POST TREATMENT ASSESSMENT- After completing intervention (Range 0.30-7.47 months; Mean=2.84 months from baseline); EXTENDED FOLLOWUP- 3-months after providing follow-up up to 1 year from enrollment (Range 3.10-11.43 months; Mean=6.32 months from baseline)]

      Suicidality will be measured using the Columbia Suicide Severity Rating Scale. The C-SSRS was used across time points to record level of ideation, lifetime suicide attempts, and recent suicide attempts. The follow-up version of C-SSRS measured suicidal ideation and behavior that had occurred since the last assessment. The scale has inter-rater reliability of .97 and has been used extensively in prospective suicide studies. The scale has a minimum value of 0 and a maximum value of 5. Higher scores mean a worse outcome (more severe ideation).

    2. Supporting Partner Caregiver Burden [POST TREATMENT ASSESSMENT- After completing intervention (Range 0.30-7.47 months; Mean=2.84 months from baseline); EXTENDED FOLLOWUP- 3-months after providing follow-up up to 1 year from enrollment (Range 3.10-11.43 months; Mean=6.32 months from baseline)]

      Caregiver burden will be evaluated by the Caregiver Burden Inventory (CBI), a 24-item scale assessing caregiver burden in four areas: physical, social, emotional and time dependence burden. Investigators found a large effect size in the pilot multifamily group study on this scale (Cohen's d = 1.03). Items were averaged to create an overall measure of caregiver burden and showed excellent internal consistency in this study (α =.94). CBI scores range from 0 (minimum) to 4 (maximum). Higher scores mean a worse outcome (greater caregiver burden).

    3. Number of Veterans With at Least 1 Suicide Attempt [POST TREATMENT ASSESSMENT- After completing intervention (Range 0.30-7.47 months; Mean=2.84 months from baseline); EXTENDED FOLLOWUP- 3-months after providing follow-up up to 1 year from enrollment (Range 3.10-11.43 months; Mean=6.32 months from baseline)]

      These are the number of Veterans who reported at least one or more behaviors coded as "actual suicide attempts" since last visit using the Columbia Suicide Severity Rating Scale (C-SSRS). The follow-up version of C-SSRS measured suicidal ideation and behavior that had occurred since the last assessment. The scale has inter-rater reliability of .97 and has been used extensively in prospective suicide studies. A behavior was considered an "actual suicide attempt" if it was a potentially self-injurious act with any intent to die associated with it.

    Secondary Outcome Measures

    1. Veteran Suicide Related Coping [POST TREATMENT ASSESSMENT- After completing intervention (Range 0.30-7.47 months; Mean=2.84 months from baseline); EXTENDED FOLLOWUP- 3-months after providing follow-up up to 1 year from enrollment (Range 3.10-11.43 months; Mean=6.32 months from baseline)]

      Suicide-related coping will be evaluated by the Stanley Suicide-related Coping Scale (SRCS), a 21-item self-report measure developed by Stanley, Green, Holloway, Brenner & Brown to evaluate appraisal of one's ability to cope with suicidal ideation and urges, as well as ability to use the Safety Plan. Examples of items are: "I am at the mercy of my suicidal thoughts", "I have several things I can do to get through a suicidal crisis". Scores were averaged so that higher scores represent greater confidence and breadth of approaches to coping with suicidal thoughts and feelings (better outcome). SRCS scores have a minimum of 0 and a maximum of 4.

    2. Veteran Thwarted Belongingness [POST TREATMENT ASSESSMENT- After completing intervention (Range 0.30-7.47 months; Mean=2.84 months from baseline); EXTENDED FOLLOWUP- 3-months after providing follow-up up to 1 year from enrollment (Range 3.10-11.43 months; Mean=6.32 months from baseline)]

      Thwarted belongingness will be evaluated by Interpersonal Needs Questionnaire (INQ-15). The INQ is has demonstrated acceptable internal consistency for thwarted belongingness in this sample (TB) (α =.79). Scores on each subscale were averaged so that higher scores represent a greater degree of their respective constructs. Thwarted belongingness scores range from 1 (minimum) to 6 (maximum). Higher scores mean a worse outcome (decreased feelings of belongingness).

    3. Partner Support of Suicide-Related Coping [POST TREATMENT ASSESSMENT- After completing intervention (Range 0.30-7.47 months; Mean=2.84 months from baseline); EXTENDED FOLLOWUP- 3-months after providing follow-up up to 1 year from enrollment (Range 3.10-11.43 months; Mean=6.32 months from baseline)]

      We have developed a family counterpart to the Stanley Suicide-related Coping Scale for Veterans that taps family members' appraisal of their ability to participate effectively in Veteran safety planning. Items include, "I recognize the triggers and warning signs for suicidal ideation/urges for my Veteran" and "I know the numbers for the mobile crisis team to contact and nearest hospital or urgent care facility to accompany my Veteran to in a crisis." This measure will be validated against the more general Family Empowerment Scale. Items were rated on a 0 (Strongly Disagree) to 4 (Strongly Agree) scale and were averaged with higher scores indicating greater self-efficacy when supporting the Veteran through suicidal crises (better outcome). Partner SRCS scores range from 0 (minimum) to 4 (maximum).

    4. Veteran Perceived Burdensomeness [POST TREATMENT ASSESSMENT- After completing intervention (Range 0.30-7.47 months; Mean=2.84 months from baseline); EXTENDED FOLLOWUP- 3-months after providing follow-up up to 1 year from enrollment (Range 3.10-11.43 months; Mean=6.32 months from baseline)]

      Perceived burdensomeness will be evaluated by Interpersonal Needs Questionnaire (INQ-15). The INQ is has demonstrated excellent internal consistency for Perceived Burdensomeness (PB) (α= .95). Scores on each subscale were averaged so that higher scores represent a greater degree of their respective constructs. Perceived burdensomeness scores range from 1 (minimum) to 6 (maximum). Higher scores mean a worse outcome (greater perceived burdensomeness).

    5. Veteran Hopelessness [POST TREATMENT ASSESSMENT- After completing intervention (Range 0.30-7.47 months; Mean=2.84 months from baseline); EXTENDED FOLLOWUP- 3-months after providing follow-up up to 1 year from enrollment (Range 3.10-11.43 months; Mean=6.32 months from baseline)]

      Veteran hopelessness will be evaluated by the Beck Hopelessness Scale (BHS), a 20-item self-report measure with adequate reliability and validity which has been predictive of suicide in psychiatric inpatients. The BHS measures three aspects of hopelessness: feelings about the future, loss of motivation, and expectations. Items are true-false and are summed to get a total BHS score, ranging from 0 to 20. Higher scores reflect a worse outcome (greater hopelessness).

    6. Veteran Depression [POST TREATMENT ASSESSMENT- After completing intervention (Range 0.30-7.47 months; Mean=2.84 months from baseline); EXTENDED FOLLOWUP- 3-months after providing follow-up up to 1 year from enrollment (Range 3.10-11.43 months; Mean=6.32 months from baseline)]

      Veteran depression will be evaluated by the widely-used Beck Depression Inventory-II (BDI-II) (Cronbach's = .92). The BDI-II contains 21 items assessing depressive symptoms, each with minimum scores of 0 and maximum scores of 3. Item scores were summed, leading to a total score range of 0-63. Higher scores mean a worse outcome (more severe depressive symptoms).

    7. Caregiver's Empowerment to Help Veteran [POST TREATMENT ASSESSMENT- After completing intervention (Range 0.30-7.47 months; Mean=2.84 months from baseline); EXTENDED FOLLOWUP- 3-months after providing follow-up up to 1 year from enrollment (Range 3.10-11.43 months; Mean=6.32 months from baseline)]

      Caregiving self-efficacy/empowerment will be evaluated using the 12-item family subscale from the Family Empowerment Scale. This scale assesses the family's knowledge of mental health services and perceived ability to manage crises, and has demonstrated sensitivity to change in family intervention studies. Each item has a minimum score of 1 and a maximum score of 5, and were averaged to create a total score range of 1-5. Higher scores mean a better outcome (greater empowerment).

    8. Veteran's Report of Family Problem Solving [POST TREATMENT ASSESSMENT- After completing intervention (Range 0.30-7.47 months; Mean=2.84 months from baseline); EXTENDED FOLLOWUP- 3-months after providing follow-up up to 1 year from enrollment (Range 3.10-11.43 months; Mean=6.32 months from baseline)]

      Veterans' reports of family problem solving will be evaluated by the 5-item Problem Solving subscale of the Family Assessment Device (FAD). Subscales have acceptable internal consistency (α = .72 to .83). Each item has a minimum score of 1 and a maximum score of 4, and were averaged to create a total score range of 1-4. Higher scores reflect worse outcomes (lower problem solving ability).

    9. Veteran's Report of Family Communication [POST TREATMENT ASSESSMENT- After completing intervention (Range 0.30-7.47 months; Mean=2.84 months from baseline); EXTENDED FOLLOWUP- 3-months after providing follow-up up to 1 year from enrollment (Range 3.10-11.43 months; Mean=6.32 months from baseline)]

      Veterans' reports of family communication will be evaluated by the 6-item Communication subscale of the Family Assessment Device (FAD). Subscales have acceptable internal consistency (α = .72 to .83). Each item has a minimum score of 1 and a maximum score of 4, and were averaged to create a total score range of 1-4. Higher scores reflect worse outcomes (worse communication).

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 89 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    Inclusion criteria-Veterans:
    • Eligible Veterans must be identified as at moderate risk for suicide, defined as:

    • evidence of current (within the past week) suicidal ideation

    • plan or intent on the Columbia Suicide Severity Rating Scale (C-SSRS), but scoring less than or equal to 4 on the C-SSRS Behavior Scale, and without history of a lethal suicide attempt in the last 3 months.

    Inclusion criteria also include the availability of a consenting, qualifying family member or spouse/cohabiting partner.

    Inclusion criteria-family member/significant others:
    • Family members/friends must meet at least three (two for nonrelatives) of five criteria:

    • is a spouse, co-habiting significant other or parent

    • has more frequent contact than any other caregiver

    • helps to support the patient financially

    • is contacted by treatment staff for emergencies

    • has been involved in the patient's treatment

    Exclusion Criteria:
    Exclusion criteria for Veterans and family/partners are:
    • untreated or un-medicated psychosis

    • current alcohol or drug abuse or dependence defined by a Patient Health Questionnaire (PHQ) for Alcohol & Drug Use

    • for couples, "severe" intimate-partner violence as defined by the revised 20-item Conflict Tactics Scale Short Form (CTS2S)

    • medical condition or life event, e.g.,

    • participation in another family-based psychosocial intervention trial six months prior to study

    • limited English proficiency. Participants will be screened for inclusion/exclusion as described above immediately after giving consent.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 James J. Peters VA Medical Center, Bronx, NY Bronx New York United States 10468

    Sponsors and Collaborators

    • VA Office of Research and Development

    Investigators

    • Principal Investigator: Marianne S. Goodman, MD, James J. Peters Veterans Affairs Medical Center

    Study Documents (Full-Text)

    More Information

    Publications

    None provided.
    Responsible Party:
    VA Office of Research and Development
    ClinicalTrials.gov Identifier:
    NCT03034863
    Other Study ID Numbers:
    • D2432-R
    • RX002432-01
    First Posted:
    Jan 27, 2017
    Last Update Posted:
    Dec 10, 2021
    Last Verified:
    Nov 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    No
    Keywords provided by VA Office of Research and Development
    Additional relevant MeSH terms:

    Study Results

    Participant Flow

    Recruitment Details The study recruited, consented, and randomized 39 Veterans at risk for suicide and 39 corresponding supporting partners over a 30-month period from a large VA medical center in a major metropolitan area in the North East. Recruitment sources included VA suicide prevention coordinators, a Veteran's primary clinician from the VA Medical Center's (VAMC) psychiatric inpatient unit or outpatient care center, or through community outreach (e.g., Vet Centers and higher education institutions).
    Pre-assignment Detail
    Arm/Group Title SAFER I-SPI
    Arm/Group Description Safe Actions for Families to Encourage Recovery (SAFER): A novel, 4-session intervention to enhance currently mandated VA suicide safety planning by involving family members to support its implementation. Incorporation of education about suicide risk factors and teaching communication skills of active listening and making a positive request will supply Veterans and family members with the knowledge and tools needed to 1) identify potential warning signs, and 2) discuss Veteran ideation or family concerns. SAFER aims to increase family support for the Veteran to directly mitigate Veteran loneliness and sense of being a burden to others. Safe Actions for Families to Encourage Recovery: A novel, 4-session intervention to enhance VA suicide safety planning by involving family members to support its implementation. The comparison condition will be an assessment-only enhanced treatment-as-usual, the currently mandated Individual Safety Planning Intervention (I-SPI). I-SPI incorporates update and use of the safety plan, which will then be uploaded to the Computerized Patient Record System (CPRS) so the Veterans' primary mental health providers can access. Treatment-as-Usual: The comparison condition will be an assessment-only enhanced treatment-as-usual called the Individual Safety Planning Intervention (I-SPI).
    Period Title: Overall Study
    STARTED 38 40
    Veterans 19 20
    Supporting Partners 19 20
    COMPLETED 28 28
    NOT COMPLETED 10 12

    Baseline Characteristics

    Arm/Group Title SAFER I-SPI Total
    Arm/Group Description SAFER: A novel, 4-session intervention to enhance currently mandated VA suicide safety planning by involving family members to support its implementation. Incorporation of education about suicide risk factors and teaching communication skills of active listening and making a positive request will supply Veterans and family members with the knowledge and tools needed to 1) identify potential warning signs, and 2) discuss Veteran ideation or family concerns with assurance that such requests will be listened to with validation and support, creating an ally for the suicidal Veteran in his struggle. As discussed above, research has demonstrated compellingly that suicidal desire is motivated by two interpersonal factors; perceived burdensomeness and thwarted belongingness. SAFER aims to increase family support for the Veteran to directly mitigate Veteran loneliness and sense of being a burden to others. Safe Actions for Families to Encourage Recovery: A novel, 4-session intervention to enhance currently mandated VA suicide safety planning by involving family members to support its implementation. The comparison condition will be an assessment-only enhanced treatment-as-usual (E-TAU), the currently mandated Individual Safety Planning Intervention (I-SPI). I-SPI incorporates weekly scripted check-in phone calls to review mood symptoms and use of the safety plan, which will then be given as feedback to the Veteran's primary mental health provider. Treatment-as-Usual: The comparison condition will be an assessment-only enhanced treatment-as-usual called the Individual Safety Planning Intervention (I-SPI). Total of all reporting groups
    Overall Participants 38 40 78
    Age (Count of Participants)
    <=18 years
    0
    0%
    0
    0%
    0
    0%
    Between 18 and 65 years
    18
    47.4%
    17
    42.5%
    35
    44.9%
    >=65 years
    1
    2.6%
    3
    7.5%
    4
    5.1%
    Age (Count of Participants)
    <=18 years
    1
    2.6%
    0
    0%
    1
    1.3%
    Between 18 and 65 years
    15
    39.5%
    19
    47.5%
    34
    43.6%
    >=65 years
    3
    7.9%
    1
    2.5%
    4
    5.1%
    Age (years) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [years]
    53.26
    (12.37)
    51.90
    (15.62)
    52.58
    (14.00)
    Age (years) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [years]
    48.68
    (16.24)
    42.55
    (12.80)
    45.62
    (14.52)
    Sex: Female, Male (Count of Participants)
    Female
    2
    5.3%
    4
    10%
    6
    7.7%
    Male
    17
    44.7%
    16
    40%
    33
    42.3%
    Sex: Female, Male (Count of Participants)
    Female
    13
    34.2%
    12
    30%
    25
    32.1%
    Male
    6
    15.8%
    8
    20%
    14
    17.9%
    Ethnicity (NIH/OMB) (Count of Participants)
    Hispanic or Latino
    5
    13.2%
    8
    20%
    13
    16.7%
    Not Hispanic or Latino
    14
    36.8%
    11
    27.5%
    25
    32.1%
    Unknown or Not Reported
    0
    0%
    1
    2.5%
    1
    1.3%
    Ethnicity (NIH/OMB) (Count of Participants)
    Hispanic or Latino
    6
    15.8%
    8
    20%
    14
    17.9%
    Not Hispanic or Latino
    13
    34.2%
    12
    30%
    25
    32.1%
    Unknown or Not Reported
    0
    0%
    0
    0%
    0
    0%
    Race (NIH/OMB) (Count of Participants)
    American Indian or Alaska Native
    0
    0%
    1
    2.5%
    1
    1.3%
    Asian
    0
    0%
    0
    0%
    0
    0%
    Native Hawaiian or Other Pacific Islander
    0
    0%
    0
    0%
    0
    0%
    Black or African American
    10
    26.3%
    10
    25%
    20
    25.6%
    White
    5
    13.2%
    2
    5%
    7
    9%
    More than one race
    2
    5.3%
    4
    10%
    6
    7.7%
    Unknown or Not Reported
    2
    5.3%
    3
    7.5%
    5
    6.4%
    Race (NIH/OMB) (Count of Participants)
    American Indian or Alaska Native
    1
    2.6%
    1
    2.5%
    2
    2.6%
    Asian
    0
    0%
    0
    0%
    0
    0%
    Native Hawaiian or Other Pacific Islander
    0
    0%
    0
    0%
    0
    0%
    Black or African American
    8
    21.1%
    10
    25%
    18
    23.1%
    White
    5
    13.2%
    2
    5%
    7
    9%
    More than one race
    1
    2.6%
    4
    10%
    5
    6.4%
    Unknown or Not Reported
    4
    10.5%
    3
    7.5%
    7
    9%
    Region of Enrollment (Count of Participants)
    United States
    19
    50%
    20
    50%
    39
    50%
    Region of Enrollment (Count of Participants)
    United States
    19
    50%
    20
    50%
    39
    50%
    Veteran Suicidal Ideation (units on a scale) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [units on a scale]
    3.26
    (1.69)
    3.75
    (1.33)
    3.51
    (1.51)
    Veteran Suicide-Related Coping (units on a scale) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [units on a scale]
    3.03
    (0.71)
    2.91
    (0.65)
    2.97
    (0.68)
    Partner Support of Suicide-Related Coping (units on a scale) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [units on a scale]
    3.23
    (0.81)
    3.37
    (0.87)
    3.3
    (0.84)
    Veteran Thwarted Belongingness (units on a scale) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [units on a scale]
    3.23
    (1.02)
    3.62
    (0.9)
    3.43
    (0.96)
    Veteran Perceived Burdensomeness (units on a scale) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [units on a scale]
    2.84
    (1.56)
    3.03
    (1.61)
    2.94
    (1.59)
    Supporting Partner Caregiver Burden (units on a scale) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [units on a scale]
    1.39
    (0.92)
    1.06
    (0.96)
    1.23
    (0.94)
    Veteran Hopelessness (units on a scale) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [units on a scale]
    6.95
    (5.79)
    11.72
    (6.57)
    9.34
    (6.18)
    Veteran Depression (units on a scale) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [units on a scale]
    24.36
    (11.75)
    32.5
    (15.56)
    28.43
    (13.66)
    Caregiver's Empowerment to Help Veteran (units on a scale) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [units on a scale]
    3.79
    (0.64)
    3.75
    (0.80)
    3.77
    (0.72)
    Veteran's Report of Family Problem Solving (units on a scale) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [units on a scale]
    2.27
    (0.62)
    2.44
    (0.74)
    2.36
    (0.68)
    Veteran's Reports of Family Communication (units on a scale) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [units on a scale]
    2.42
    (0.37)
    2.53
    (0.41)
    2.48
    (0.39)
    Number of Veterans with at least 1 Suicide Attempt (Count of Participants)
    Count of Participants [Participants]
    10
    26.3%
    9
    22.5%
    19
    24.4%

    Outcome Measures

    1. Primary Outcome
    Title Veteran Suicidal Ideation
    Description Suicidality will be measured using the Columbia Suicide Severity Rating Scale. The C-SSRS was used across time points to record level of ideation, lifetime suicide attempts, and recent suicide attempts. The follow-up version of C-SSRS measured suicidal ideation and behavior that had occurred since the last assessment. The scale has inter-rater reliability of .97 and has been used extensively in prospective suicide studies. The scale has a minimum value of 0 and a maximum value of 5. Higher scores mean a worse outcome (more severe ideation).
    Time Frame POST TREATMENT ASSESSMENT- After completing intervention (Range 0.30-7.47 months; Mean=2.84 months from baseline); EXTENDED FOLLOWUP- 3-months after providing follow-up up to 1 year from enrollment (Range 3.10-11.43 months; Mean=6.32 months from baseline)

    Outcome Measure Data

    Analysis Population Description
    Some participants lost between baseline and post-treatment follow-up and extended 3 month follow up. These groups specifically refer to Veterans (does not include supporting partners) and therefore include about half of the total participants in the study.
    Arm/Group Title Veterans in SAFER Veterans in I-SPI
    Arm/Group Description Veteran participants in the SAFER (intervention) condition Veterans in the I-SPI (control) condition
    Measure Participants 15 15
    Post-Treatment
    1.50
    (1.93)
    3.50
    (1.43)
    Extended Follow-Up
    1.00
    (1.31)
    3.38
    (2.13)
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection Veterans in SAFER, Veterans in I-SPI
    Comments
    Type of Statistical Test Superiority
    Comments
    Statistical Test of Hypothesis p-Value .03
    Comments All p-values are two-tailed
    Method Hierarchical Linear Modeling/MLM
    Comments Hypothesis tested using a dummy code representing group assignment (1=SAFER; 0=I-SPI) in the Level 2 equation for the slope term.
    Method of Estimation Estimation Parameter Slope
    Estimated Value -0.37
    Confidence Interval (2-Sided) %
    to
    Parameter Dispersion Type: Standard Error of the Mean
    Value: 0.17
    Estimation Comments Slope represents relative unit change/month between both conditions. Positive slope terms represent relative increases in SAFER compared to I-SPI. Negative slope terms represent relative reductions in SAFER compared to I-SPI.
    2. Primary Outcome
    Title Supporting Partner Caregiver Burden
    Description Caregiver burden will be evaluated by the Caregiver Burden Inventory (CBI), a 24-item scale assessing caregiver burden in four areas: physical, social, emotional and time dependence burden. Investigators found a large effect size in the pilot multifamily group study on this scale (Cohen's d = 1.03). Items were averaged to create an overall measure of caregiver burden and showed excellent internal consistency in this study (α =.94). CBI scores range from 0 (minimum) to 4 (maximum). Higher scores mean a worse outcome (greater caregiver burden).
    Time Frame POST TREATMENT ASSESSMENT- After completing intervention (Range 0.30-7.47 months; Mean=2.84 months from baseline); EXTENDED FOLLOWUP- 3-months after providing follow-up up to 1 year from enrollment (Range 3.10-11.43 months; Mean=6.32 months from baseline)

    Outcome Measure Data

    Analysis Population Description
    Some participants lost between baseline and post-treatment follow-up and extended 3-month follow-up. These groups specifically refer to supporting partners (does not include Veterans) and therefore include about half of the total participants in the study.
    Arm/Group Title Caregivers in SAFER Caregivers in I-SPI
    Arm/Group Description Caregivers in the SAFER (intervention) condition Caregivers in the I-SPI (control) condition
    Measure Participants 13 13
    Post-Treatment
    1.23
    (0.85)
    1.00
    (0.86)
    Extended Follow-Up
    0.90
    (0.59)
    0.72
    (0.67)
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection Veterans in SAFER, Veterans in I-SPI
    Comments
    Type of Statistical Test Superiority
    Comments
    Statistical Test of Hypothesis p-Value .69
    Comments
    Method Hierarchical Linear Modeling/MLM
    Comments Hypothesis tested using a dummy code representing group assignment (1=SAFER; 0=I-SPI) in the Level 2 equation for the slope term.
    Method of Estimation Estimation Parameter Slope
    Estimated Value -0.02
    Confidence Interval (2-Sided) %
    to
    Parameter Dispersion Type: Standard Error of the Mean
    Value: 0.05
    Estimation Comments Slope represents relative unit change/month between both conditions. Positive slope terms represent relative increases in SAFER compared to I-SPI. Negative slope terms represent relative reductions in SAFER compared to I-SPI.
    3. Primary Outcome
    Title Number of Veterans With at Least 1 Suicide Attempt
    Description These are the number of Veterans who reported at least one or more behaviors coded as "actual suicide attempts" since last visit using the Columbia Suicide Severity Rating Scale (C-SSRS). The follow-up version of C-SSRS measured suicidal ideation and behavior that had occurred since the last assessment. The scale has inter-rater reliability of .97 and has been used extensively in prospective suicide studies. A behavior was considered an "actual suicide attempt" if it was a potentially self-injurious act with any intent to die associated with it.
    Time Frame POST TREATMENT ASSESSMENT- After completing intervention (Range 0.30-7.47 months; Mean=2.84 months from baseline); EXTENDED FOLLOWUP- 3-months after providing follow-up up to 1 year from enrollment (Range 3.10-11.43 months; Mean=6.32 months from baseline)

    Outcome Measure Data

    Analysis Population Description
    Some participants lost between baseline and post-treatment follow-up and extended 3-month follow-up. These groups specifically refer to Veterans (does not include supporting partners) and therefore include about half of the total participants in the study.
    Arm/Group Title Veterans in SAFER Veterans in I-SPI
    Arm/Group Description Veteran participants in the SAFER (intervention) condition Veterans in the I-SPI (control) condition
    Measure Participants 15 15
    Post-Treatment
    0
    0%
    2
    5%
    Extended Follow-Up
    0
    0%
    1
    2.5%
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection Veterans in SAFER, Veterans in I-SPI
    Comments
    Type of Statistical Test Superiority
    Comments
    Statistical Test of Hypothesis p-Value .49
    Comments All p-values are two-tailed
    Method Fisher Exact
    Comments Compares veterans who reported 1+ attempts at any follow-up wave out of total number of veterans in each group (i.e., 0/19 for SAFER; 2/20 for I-SPI).
    4. Secondary Outcome
    Title Veteran Suicide Related Coping
    Description Suicide-related coping will be evaluated by the Stanley Suicide-related Coping Scale (SRCS), a 21-item self-report measure developed by Stanley, Green, Holloway, Brenner & Brown to evaluate appraisal of one's ability to cope with suicidal ideation and urges, as well as ability to use the Safety Plan. Examples of items are: "I am at the mercy of my suicidal thoughts", "I have several things I can do to get through a suicidal crisis". Scores were averaged so that higher scores represent greater confidence and breadth of approaches to coping with suicidal thoughts and feelings (better outcome). SRCS scores have a minimum of 0 and a maximum of 4.
    Time Frame POST TREATMENT ASSESSMENT- After completing intervention (Range 0.30-7.47 months; Mean=2.84 months from baseline); EXTENDED FOLLOWUP- 3-months after providing follow-up up to 1 year from enrollment (Range 3.10-11.43 months; Mean=6.32 months from baseline)

    Outcome Measure Data

    Analysis Population Description
    Some participants lost between baseline and post-treatment follow-up and extended 3-month follow-up. These groups specifically refer to Veterans (does not include supporting partners) and therefore include about half of the total participants in the study.
    Arm/Group Title Veterans in SAFER Veterans in I-SPI
    Arm/Group Description Veteran participants in the SAFER (intervention) condition Veterans in the I-SPI (control) condition
    Measure Participants 15 15
    Post-Treatment
    3.15
    (0.71)
    2.69
    (1.02)
    Extended Follow-Up
    3.12
    (0.59)
    2.70
    (0.86)
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection Veterans in SAFER, Veterans in I-SPI
    Comments
    Type of Statistical Test Superiority
    Comments
    Statistical Test of Hypothesis p-Value .03
    Comments
    Method Hierarchical Linear Modeling/MLM
    Comments Hypothesis tested using a dummy code representing group assignment (1=SAFER; 0=I-SPI) in the Level 2 equation for the slope term.
    Method of Estimation Estimation Parameter Slope
    Estimated Value 0.08
    Confidence Interval (2-Sided) %
    to
    Parameter Dispersion Type: Standard Error of the Mean
    Value: 0.04
    Estimation Comments Slope represents relative unit change/month between both conditions. Positive slope terms represent relative increases in SAFER compared to I-SPI. Negative slope terms represent relative reductions in SAFER compared to I-SPI.
    5. Secondary Outcome
    Title Veteran Thwarted Belongingness
    Description Thwarted belongingness will be evaluated by Interpersonal Needs Questionnaire (INQ-15). The INQ is has demonstrated acceptable internal consistency for thwarted belongingness in this sample (TB) (α =.79). Scores on each subscale were averaged so that higher scores represent a greater degree of their respective constructs. Thwarted belongingness scores range from 1 (minimum) to 6 (maximum). Higher scores mean a worse outcome (decreased feelings of belongingness).
    Time Frame POST TREATMENT ASSESSMENT- After completing intervention (Range 0.30-7.47 months; Mean=2.84 months from baseline); EXTENDED FOLLOWUP- 3-months after providing follow-up up to 1 year from enrollment (Range 3.10-11.43 months; Mean=6.32 months from baseline)

    Outcome Measure Data

    Analysis Population Description
    Some participants lost between baseline and post-treatment follow-up and extended 3-month follow-up. These groups specifically refer to Veterans (does not include supporting partners) and therefore include about half of the total participants in the study.
    Arm/Group Title Veterans in SAFER Veterans in I-SPI
    Arm/Group Description Veteran participants in the SAFER (treatment) condition Veterans in the I-SPI (control) condition
    Measure Participants 15 15
    Post-Treatment
    2.85
    (1.27)
    3.57
    (1.22)
    Extended Follow-Up
    3.30
    (1.46)
    3.45
    (0.95)
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection Veterans in SAFER, Veterans in I-SPI
    Comments
    Type of Statistical Test Superiority
    Comments
    Statistical Test of Hypothesis p-Value .87
    Comments
    Method Hierarchical Linear Modeling/MLM
    Comments Hypothesis tested using a dummy code representing group assignment (1=SAFER; 0=I-SPI) in the Level 2 equation for the slope term.
    Method of Estimation Estimation Parameter Slope
    Estimated Value 0.01
    Confidence Interval (2-Sided) %
    to
    Parameter Dispersion Type: Standard Error of the Mean
    Value: 0.07
    Estimation Comments Slope represents relative unit change/month between both conditions. Positive slope terms represent relative increases in SAFER compared to I-SPI. Negative slope terms represent relative reductions in SAFER compared to I-SPI.
    6. Secondary Outcome
    Title Partner Support of Suicide-Related Coping
    Description We have developed a family counterpart to the Stanley Suicide-related Coping Scale for Veterans that taps family members' appraisal of their ability to participate effectively in Veteran safety planning. Items include, "I recognize the triggers and warning signs for suicidal ideation/urges for my Veteran" and "I know the numbers for the mobile crisis team to contact and nearest hospital or urgent care facility to accompany my Veteran to in a crisis." This measure will be validated against the more general Family Empowerment Scale. Items were rated on a 0 (Strongly Disagree) to 4 (Strongly Agree) scale and were averaged with higher scores indicating greater self-efficacy when supporting the Veteran through suicidal crises (better outcome). Partner SRCS scores range from 0 (minimum) to 4 (maximum).
    Time Frame POST TREATMENT ASSESSMENT- After completing intervention (Range 0.30-7.47 months; Mean=2.84 months from baseline); EXTENDED FOLLOWUP- 3-months after providing follow-up up to 1 year from enrollment (Range 3.10-11.43 months; Mean=6.32 months from baseline)

    Outcome Measure Data

    Analysis Population Description
    Some participants lost between baseline and post-treatment follow-up and extended 3-month follow-up. These groups specifically refer to supporting partners (does not include Veterans) and therefore include about half of the total participants in the study.
    Arm/Group Title Caregivers in SAFER Caregivers in I-SPI
    Arm/Group Description Caregivers in the SAFER (intervention) condition Caregivers in the I-SPI (control) condition
    Measure Participants 13 13
    Post-Treatment
    3.65
    (0.46)
    3.36
    (0.71)
    Extended Follow-Up
    3.70
    (0.57)
    2.89
    (1.4)
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection Veterans in SAFER, Veterans in I-SPI
    Comments
    Type of Statistical Test Superiority
    Comments
    Statistical Test of Hypothesis p-Value .03
    Comments
    Method Hierarchical Linear Modeling/MLM
    Comments Hypothesis tested using a dummy code representing group assignment (1=SAFER; 0=I-SPI) in the Level 2 equation for the slope term.
    Method of Estimation Estimation Parameter Slope
    Estimated Value 0.17
    Confidence Interval (2-Sided) %
    to
    Parameter Dispersion Type: Standard Error of the Mean
    Value: 0.08
    Estimation Comments Slope represents relative unit change/month between both conditions. Positive slope terms represent relative increases in SAFER compared to I-SPI. Negative slope terms represent relative reductions in SAFER compared to I-SPI.
    7. Secondary Outcome
    Title Veteran Perceived Burdensomeness
    Description Perceived burdensomeness will be evaluated by Interpersonal Needs Questionnaire (INQ-15). The INQ is has demonstrated excellent internal consistency for Perceived Burdensomeness (PB) (α= .95). Scores on each subscale were averaged so that higher scores represent a greater degree of their respective constructs. Perceived burdensomeness scores range from 1 (minimum) to 6 (maximum). Higher scores mean a worse outcome (greater perceived burdensomeness).
    Time Frame POST TREATMENT ASSESSMENT- After completing intervention (Range 0.30-7.47 months; Mean=2.84 months from baseline); EXTENDED FOLLOWUP- 3-months after providing follow-up up to 1 year from enrollment (Range 3.10-11.43 months; Mean=6.32 months from baseline)

    Outcome Measure Data

    Analysis Population Description
    Some participants lost between baseline and post-treatment follow-up and extended 3-month follow-up. These groups specifically refer to Veterans (does not include supporting partners) and therefore include about half of the total participants in the study.
    Arm/Group Title Veterans in SAFER Veterans in I-SPI
    Arm/Group Description Veteran participants in the SAFER (intervention) condition Veterans in the I-SPI (control) condition
    Measure Participants 15 15
    Post-Treatment
    2.23
    (1.39)
    2.60
    (1.68)
    Extended Follow-Up
    2.10
    (1.63)
    2.86
    (1.42)
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection Veterans in SAFER, Veterans in I-SPI
    Comments
    Type of Statistical Test Superiority
    Comments
    Statistical Test of Hypothesis p-Value .16
    Comments
    Method Hierarchical Linear Modeling/MLM
    Comments Hypothesis tested using a dummy code representing group assignment (1=SAFER; 0=I-SPI) in the Level 2 equation for the slope term.
    Method of Estimation Estimation Parameter Slope
    Estimated Value -0.12
    Confidence Interval (2-Sided) %
    to
    Parameter Dispersion Type: Standard Error of the Mean
    Value: 0.08
    Estimation Comments Slope represents relative unit change/month between both conditions. Positive slope terms represent relative increases in SAFER compared to I-SPI. Negative slope terms represent relative reductions in SAFER compared to I-SPI.
    8. Secondary Outcome
    Title Veteran Hopelessness
    Description Veteran hopelessness will be evaluated by the Beck Hopelessness Scale (BHS), a 20-item self-report measure with adequate reliability and validity which has been predictive of suicide in psychiatric inpatients. The BHS measures three aspects of hopelessness: feelings about the future, loss of motivation, and expectations. Items are true-false and are summed to get a total BHS score, ranging from 0 to 20. Higher scores reflect a worse outcome (greater hopelessness).
    Time Frame POST TREATMENT ASSESSMENT- After completing intervention (Range 0.30-7.47 months; Mean=2.84 months from baseline); EXTENDED FOLLOWUP- 3-months after providing follow-up up to 1 year from enrollment (Range 3.10-11.43 months; Mean=6.32 months from baseline)

    Outcome Measure Data

    Analysis Population Description
    Some participants lost between baseline and post-treatment follow-up and extended 3 month follow up. These groups specifically refer to Veterans (does not include supporting partners) and therefore include about half of the total participants in the study.
    Arm/Group Title Veterans in SAFER Veterans in I-SPI
    Arm/Group Description Veteran participants in the SAFER (intervention) condition Veterans in the I-SPI (control) condition
    Measure Participants 15 15
    Post-Treatment
    7.40
    (6.49)
    11.73
    (7.06)
    Extended Follow-Up
    9.09
    (7.84)
    12.61
    (6.70)
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection Veterans in SAFER, Veterans in I-SPI
    Comments
    Type of Statistical Test Superiority
    Comments
    Statistical Test of Hypothesis p-Value .81
    Comments All p-values are two-tailed
    Method Hierarchical Linear Modeling/MLM
    Comments Hypothesis tested using a dummy code representing group assignment (1=SAFER; 0=I-SPI) in the Level 2 equation for the slope term.
    Method of Estimation Estimation Parameter Slope
    Estimated Value .09
    Confidence Interval (2-Sided) %
    to
    Parameter Dispersion Type: Standard Error of the Mean
    Value: .35
    Estimation Comments Slope represents relative unit change/month between both conditions. Positive slope terms represent relative increases in SAFER compared to I-SPI. Negative slope terms represent relative reductions in SAFER compared to I-SPI.
    9. Secondary Outcome
    Title Veteran Depression
    Description Veteran depression will be evaluated by the widely-used Beck Depression Inventory-II (BDI-II) (Cronbach's = .92). The BDI-II contains 21 items assessing depressive symptoms, each with minimum scores of 0 and maximum scores of 3. Item scores were summed, leading to a total score range of 0-63. Higher scores mean a worse outcome (more severe depressive symptoms).
    Time Frame POST TREATMENT ASSESSMENT- After completing intervention (Range 0.30-7.47 months; Mean=2.84 months from baseline); EXTENDED FOLLOWUP- 3-months after providing follow-up up to 1 year from enrollment (Range 3.10-11.43 months; Mean=6.32 months from baseline)

    Outcome Measure Data

    Analysis Population Description
    Some participants lost between baseline and post-treatment follow-up and extended 3-month follow-up. These groups specifically refer to Veterans (does not include supporting partners) and therefore include about half of the total participants in the study.
    Arm/Group Title Veterans in SAFER Veterans in I-SPI
    Arm/Group Description Veteran participants in the SAFER (intervention) condition Veterans in the I-SPI (control) condition
    Measure Participants 15 15
    Post-Treatment
    21.20
    (16.92)
    29.07
    (18.67)
    Extended Follow-Up
    18.33
    (16.20)
    31.08
    (17.67)
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection Veterans in SAFER, Veterans in I-SPI
    Comments
    Type of Statistical Test Superiority
    Comments
    Statistical Test of Hypothesis p-Value .55
    Comments All p-values are two-tailed
    Method Hierarchical Linear Modeling/MLM
    Comments Hypothesis tested using a dummy code representing group assignment (1=SAFER; 0=I-SPI) in the Level 2 equation for the slope term.
    Method of Estimation Estimation Parameter Slope
    Estimated Value -.37
    Confidence Interval (2-Sided) %
    to
    Parameter Dispersion Type: Standard Error of the Mean
    Value: .62
    Estimation Comments Slope represents relative unit change/month between both conditions. Positive slope terms represent relative increases in SAFER compared to I-SPI. Negative slope terms represent relative reductions in SAFER compared to I-SPI.
    10. Secondary Outcome
    Title Caregiver's Empowerment to Help Veteran
    Description Caregiving self-efficacy/empowerment will be evaluated using the 12-item family subscale from the Family Empowerment Scale. This scale assesses the family's knowledge of mental health services and perceived ability to manage crises, and has demonstrated sensitivity to change in family intervention studies. Each item has a minimum score of 1 and a maximum score of 5, and were averaged to create a total score range of 1-5. Higher scores mean a better outcome (greater empowerment).
    Time Frame POST TREATMENT ASSESSMENT- After completing intervention (Range 0.30-7.47 months; Mean=2.84 months from baseline); EXTENDED FOLLOWUP- 3-months after providing follow-up up to 1 year from enrollment (Range 3.10-11.43 months; Mean=6.32 months from baseline)

    Outcome Measure Data

    Analysis Population Description
    Some participants lost between baseline and post-treatment follow-up and extended 3-month follow-up. These groups specifically refer to supporting partners (does not include Veterans) and therefore include about half of the total participants in the study.
    Arm/Group Title Caregivers in SAFER Caregivers in I-SPI
    Arm/Group Description Caregivers in the SAFER (intervention) condition Caregivers in the I-SPI (control) condition
    Measure Participants 13 13
    Post-Treatment
    3.71
    (0.78)
    3.91
    (0.94)
    Extended Follow-Up
    3.91
    (0.67)
    3.87
    (0.86)
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection Veterans in SAFER, Veterans in I-SPI
    Comments
    Type of Statistical Test Superiority
    Comments
    Statistical Test of Hypothesis p-Value .64
    Comments All p-values are two-tailed
    Method Hierarchical Linear Modeling/MLM
    Comments Hypothesis tested using a dummy code representing group assignment (1=SAFER; 0=I-SPI) in the Level 2 equation for the slope term.
    Method of Estimation Estimation Parameter Slope
    Estimated Value .02
    Confidence Interval (2-Sided) %
    to
    Parameter Dispersion Type: Standard Error of the Mean
    Value: .05
    Estimation Comments Slope represents relative unit change/month between both conditions. Positive slope terms represent relative increases in SAFER compared to I-SPI. Negative slope terms represent relative reductions in SAFER compared to I-SPI.
    11. Secondary Outcome
    Title Veteran's Report of Family Problem Solving
    Description Veterans' reports of family problem solving will be evaluated by the 5-item Problem Solving subscale of the Family Assessment Device (FAD). Subscales have acceptable internal consistency (α = .72 to .83). Each item has a minimum score of 1 and a maximum score of 4, and were averaged to create a total score range of 1-4. Higher scores reflect worse outcomes (lower problem solving ability).
    Time Frame POST TREATMENT ASSESSMENT- After completing intervention (Range 0.30-7.47 months; Mean=2.84 months from baseline); EXTENDED FOLLOWUP- 3-months after providing follow-up up to 1 year from enrollment (Range 3.10-11.43 months; Mean=6.32 months from baseline)

    Outcome Measure Data

    Analysis Population Description
    Some participants lost between baseline and post-treatment follow-up and extended 3-month follow-up. These groups specifically refer to Veterans (does not include supporting partners) and therefore include about half of the total participants in the study.
    Arm/Group Title Veterans in SAFER Veterans in I-SPI
    Arm/Group Description Veteran participants in the SAFER (intervention) condition Veterans in the I-SPI (control) condition
    Measure Participants 15 15
    Post-Treatment
    2.33
    (0.86)
    2.23
    (0.81)
    Extended Follow-Up
    2.36
    (0.64)
    2.40
    (1.01)
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection Veterans in SAFER, Veterans in I-SPI
    Comments
    Type of Statistical Test Superiority
    Comments
    Statistical Test of Hypothesis p-Value .62
    Comments All p-values are two-tailed
    Method Hierarchical Linear Modeling/MLM
    Comments Hypothesis tested using a dummy code representing group assignment (1=SAFER; 0=I-SPI) in the Level 2 equation for the slope term.
    Method of Estimation Estimation Parameter Slope
    Estimated Value -.02
    Confidence Interval (2-Sided) %
    to
    Parameter Dispersion Type: Standard Error of the Mean
    Value: .04
    Estimation Comments Slope represents relative unit change/month between both conditions. Positive slope terms represent relative increases in SAFER compared to I-SPI. Negative slope terms represent relative reductions in SAFER compared to I-SPI.
    12. Secondary Outcome
    Title Veteran's Report of Family Communication
    Description Veterans' reports of family communication will be evaluated by the 6-item Communication subscale of the Family Assessment Device (FAD). Subscales have acceptable internal consistency (α = .72 to .83). Each item has a minimum score of 1 and a maximum score of 4, and were averaged to create a total score range of 1-4. Higher scores reflect worse outcomes (worse communication).
    Time Frame POST TREATMENT ASSESSMENT- After completing intervention (Range 0.30-7.47 months; Mean=2.84 months from baseline); EXTENDED FOLLOWUP- 3-months after providing follow-up up to 1 year from enrollment (Range 3.10-11.43 months; Mean=6.32 months from baseline)

    Outcome Measure Data

    Analysis Population Description
    Some participants lost between baseline and post-treatment follow-up and extended 3-month follow-up. These groups specifically refer to Veterans (does not include supporting partners) and therefore include about half of the total participants in the study.
    Arm/Group Title Veterans in SAFER Veterans in I-SPI
    Arm/Group Description Veteran participants in the SAFER (intervention) condition Veterans in the I-SPI (control) condition
    Measure Participants 15 15
    Post-Treatment
    2.34
    (0.39)
    2.33
    (0.54)
    Extended Follow-Up
    2.33
    (0.28)
    2.27
    (0.44)
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection Veterans in SAFER, Veterans in I-SPI
    Comments
    Type of Statistical Test Superiority
    Comments
    Statistical Test of Hypothesis p-Value .16
    Comments All p-values are two-tailed
    Method Hierarchical Linear Modeling/MLM
    Comments Hypothesis tested using a dummy code representing group assignment (1=SAFER; 0=I-SPI) in the Level 2 equation for the slope term.
    Method of Estimation Estimation Parameter Slope
    Estimated Value .04
    Confidence Interval (2-Sided) %
    to
    Parameter Dispersion Type: Standard Error of the Mean
    Value: .03
    Estimation Comments Slope represents relative unit change/month between both conditions. Positive slope terms represent relative increases in SAFER compared to I-SPI. Negative slope terms represent relative reductions in SAFER compared to I-SPI.

    Adverse Events

    Time Frame 1 year, 8 months
    Adverse Event Reporting Description
    Arm/Group Title SAFER: Veterans I-SPI: Veterans SAFER: Caregivers I-SPI: Caregivers
    Arm/Group Description SAFER: A novel, 4-session intervention to enhance currently mandated VA suicide safety planning by involving family members to support its implementation. Incorporation of education about suicide risk factors and teaching communication skills of active listening and making a positive request will supply Veterans and family members with the knowledge and tools needed to 1) identify potential warning signs, and 2) discuss Veteran ideation or family concerns. SAFER aims to increase family support for the Veteran to directly mitigate Veteran loneliness and sense of being a burden to others. Safe Actions for Families to Encourage Recovery: A novel, 4-session intervention to enhance VA suicide safety planning by involving family members to support its implementation. The comparison condition will be an assessment-only enhanced treatment-as-usual (E-TAU), incorporating update and use of the safety plan, which will then be uploaded to CPRS so the Veterans' primary mental health providers can access. Treatment-as-Usual: The comparison condition will be an assessment-only enhanced treatment-as-usual (TAU). SAFER: A novel, 4-session intervention to enhance currently mandated VA suicide safety planning by involving family members to support its implementation. Incorporation of education about suicide risk factors and teaching communication skills of active listening and making a positive request will supply Veterans and family members with the knowledge and tools needed to 1) identify potential warning signs, and 2) discuss Veteran ideation or family concerns. SAFER aims to increase family support for the Veteran to directly mitigate Veteran loneliness and sense of being a burden to others. The comparison condition will be an assessment-only enhanced treatment-as-usual (E-TAU), incorporating update and use of the safety plan, which will then be uploaded to CPRS so the Veterans' primary mental health providers can access. Treatment-as-Usual: The comparison condition will be an assessment-only enhanced treatment-as-usual (TAU).
    All Cause Mortality
    SAFER: Veterans I-SPI: Veterans SAFER: Caregivers I-SPI: Caregivers
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/19 (0%) 1/20 (5%) 0/19 (0%) 1/20 (5%)
    Serious Adverse Events
    SAFER: Veterans I-SPI: Veterans SAFER: Caregivers I-SPI: Caregivers
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 1/19 (5.3%) 2/20 (10%) 0/19 (0%) 0/20 (0%)
    Psychiatric disorders
    Psychiatric Hospitalization 1/19 (5.3%) 1 1/20 (5%) 1 0/19 (0%) 0 0/20 (0%) 0
    Surgical and medical procedures
    Knee Operation 0/19 (0%) 0 1/20 (5%) 1 0/19 (0%) 0 0/20 (0%) 0
    Other (Not Including Serious) Adverse Events
    SAFER: Veterans I-SPI: Veterans SAFER: Caregivers I-SPI: Caregivers
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 1/19 (5.3%) 1/20 (5%) 0/19 (0%) 0/20 (0%)
    Nervous system disorders
    ER for Dizziness 0/19 (0%) 0 1/20 (5%) 1 0/19 (0%) 0 0/20 (0%) 0
    Renal and urinary disorders
    ER for Urination Issue 1/19 (5.3%) 1 0/20 (0%) 0 0/19 (0%) 0 0/20 (0%) 0

    Limitations/Caveats

    The proposed evaluation of SAFER has limitations. First, our strategy only targeted moderate risk suicidal Veterans. Second, there was a relatively small sample size of 39 suicidal Veterans and 39 supporting partners. Third, conducting the study in a high density, urban setting may result in different findings than if conducted in a rural setting. Fourth, the study arms were not matched for treatment dosage (SAFER: 4 sessions versus I-SPI: single session).

    More Information

    Certain Agreements

    All Principal Investigators ARE employed by the organization sponsoring the study.

    There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

    Results Point of Contact

    Name/Title Marianne Goodman, MD
    Organization James J Peters VAMC
    Phone 718-584-9000 ext 5188
    Email Marianne.Goodman@va.gov
    Responsible Party:
    VA Office of Research and Development
    ClinicalTrials.gov Identifier:
    NCT03034863
    Other Study ID Numbers:
    • D2432-R
    • RX002432-01
    First Posted:
    Jan 27, 2017
    Last Update Posted:
    Dec 10, 2021
    Last Verified:
    Nov 1, 2021